SCHEMBL29959911

SCHEMBL29959911

N#CC1CCOc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB2 P05107 1/20 0.41
ICAM1 P05362 1/20 0.41
ITGAL P20701 1/20 0.41
DPP4 P27487 1/20 0.39
LMNA P02545 2/20 0.38
CRHBP P24387 2/20 0.38
CRHR2 Q13324 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HTT P42858 1/20 0.38
MAP3K14 Q99558 1/20 0.35
SSTR4 P31391 1/20 0.34
TRPV1 Q8NER1 2/20 0.34
HTR2A P28223 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.32
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32
LRRK2 Q5S007 1/20 0.32
LTB4R Q15722 1/20 0.32
LTB4R2 Q9NPC1 1/20 0.32
OPRL1 P41146 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL768353 1.00 ITGB2 (0.41) ITGB2ICAM1ITGALDPP4LMNA
SCHEMBL29961242 0.89 ITGB2 (0.39) ITGB2ICAM1ITGALDPP4LMNA
SCHEMBL97553 0.81 ITGB2 (0.41) ITGB2ICAM1ITGALDPP4LMNA
SCHEMBL4524534 0.81 IMPDH2 (0.41) ITGB2ICAM1ITGALHTR2AABCG2
SCHEMBL26769086 0.77 ITGB2 (0.38) ITGB2ICAM1ITGALLMNACRHBP
SCHEMBL23704789 0.76 ADRA2A (0.47) LMNAHTTMAP3K14
SCHEMBL9432676 0.76 ADRA2A (0.38) LMNASMN1; SMN2TRPV1
SCHEMBL2776662 0.76 HSD17B2 (0.39) LMNAHTTMAP3K14TRPV1LRRK2
SCHEMBL7128481 0.76 CYP19A1 (0.44) ITGB2ICAM1ITGAL
SCHEMBL8083561 0.75 ITGB2 (0.46) ITGB2ICAM1ITGALLMNACRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022204150-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS BLUE OAK PHARMACEUTICALS, INC. (US) 2022-09-29 WO disclosed